Articles: pandemics.
Showing all 15,378 articles tagged:
Pandemics
-
Chinese medical journal · Oct 2022
Observational StudySwitching between eltrombopag and recombinant human thrombopoietin in patients with immune thrombocytopenia: an observational study.
Recombinant human thrombopoietin (rh-TPO) and eltrombopag are two distinct TPO receptor agonists (TPO-RAs) with different mechanisms. During the pandemic, when immunosuppressive medications are controversial, switching to another TPO-RA may be worth exploring in patients who do not benefit from their first TPO-RA. We investigated the outcomes of switching from rh-TPO to eltrombopag or vice versa in immune thrombocytopenia (ITP) patients. ⋯ ClinicalTrials.gov, NCT04214951.